Imagion Biosystems Limited (IBX.AX)
AUD 0.02
(5.56%)
AUD 0.02
(5.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.36 Million | 473.42 Thousand | 232.86 Thousand | 205.71 Thousand | 410.85 Thousand | 191.47 Thousand |
| Cost of Revenue | 5.25 Million | 3.61 Million | 2.7 Million | 2.86 Million | 2.26 Million | 3.29 Million |
| Gross Profit | -3.88 Million | -3.14 Million | -2.47 Million | -2.65 Million | -1.85 Million | -3.1 Million |
| Operating Expenses | 15.53 Million | 12.7 Million | 8.87 Million | 7.95 Million | 5.88 Million | 9.14 Million |
| Selling, General and Administrative Expenses | 10.28 Million | 5.51 Million | 3.75 Million | 2.82 Million | 1.81 Million | 3.96 Million |
| Research and Development Expenses | 5.25 Million | 3.61 Million | 2.7 Million | 2.86 Million | 2.26 Million | 3.29 Million |
| Other Expenses | - | 3.56 Million | 2.4 Million | 2.27 Million | 1.79 Million | 1.88 Million |
| Cost and Expenses | 16.71 Million | 12.7 Million | 8.87 Million | 7.95 Million | 5.88 Million | 9.14 Million |
| Operating Income | -15.81 Million | -9.8 Million | -6.02 Million | -5.35 Million | -3.42 Million | -8.33 Million |
| Interest Expense | 1.12 Million | 1985.00 | 4302.00 | 6465.00 | 9158.00 | 7753.00 |
| Income Tax Expense | -3.53 Million | 1985.00 | 2.61 Million | 2.43 Million | 2.03 Million | 7753.00 |
| Earnings before Tax | -16 Million | -9.8 Million | -6.02 Million | -5.36 Million | -3.43 Million | -8.34 Million |
| Net Income | -12.47 Million | -9.8 Million | -8.63 Million | -7.79 Million | -5.46 Million | -8.34 Million |
| Earnings Per Share Basic | -0.41 | -0.35 | -0.33 | -0.42 | -0.61 | -0.04 |
| Earnings Per Share Diluted | -0.41 | -0.35 | -0.33 | -0.42 | -0.61 | -0.04 |
| Weighted Average Shares Outstanding | 30.48 Million | 28.03 Million | 26.18 Million | 18.67 Million | 8.98 Million | 234.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.48 Million | 28.03 Million | 26.18 Million | 18.67 Million | 8.98 Million | 234.27 Million |
| Gross Margin | -2.84 | -6.64 | -10.61 | -12.91 | -4.52 | -16.21 |
| EBIT Margin | -10.02 | -18.37 | -24.12 | -24.29 | -7.99 | -42.40 |
| Profit Margin | -9.12 | -20.72 | -37.10 | -37.89 | -13.30 | -43.60 |
| EBITDA | -13.69 Million | -9.48 Million | -5.89 Million | -5.19 Million | -3.27 Million | -8.11 Million |
| Earnings Before Tax Margin | -11.56 | -20.71 | -25.85 | -26.04 | -8.33 | -43.52 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 817.52 Thousand | 817.52 Thousand | 1.08 Million | 746.66 Thousand | 2.14 Million | 690.01 Thousand |
| Cost of Revenue | 166.42 Thousand | 166.42 Thousand | 5.25 Million | 1.52 Million | 1.52 Million | 1.1 Million |
| Gross Profit | 651.09 Thousand | 651.09 Thousand | -4.16 Million | -774.47 Thousand | 619.23 Thousand | -414.14 Thousand |
| Operating Expenses | 1.08 Million | 1.08 Million | 15.53 Million | 8.2 Million | 2.75 Million | 7.33 Million |
| Selling, General and Administrative Expenses | 920.25 Thousand | 920.25 Thousand | - | 5.16 Million | 2.58 Million | 5.12 Million |
| Research and Development Expenses | 166.42 Thousand | 166.42 Thousand | - | 3.04 Million | 1.52 Million | 2.2 Million |
| Other Expenses | - | - | 3.93 Million | - | - | - |
| Cost and Expenses | 1.25 Million | 1.25 Million | 16.71 Million | 8.8 Million | 4.27 Million | 7.91 Million |
| Operating Income | -435.58 Thousand | -435.58 Thousand | -15.63 Million | -8.05 Million | -2.26 Million | -7.22 Million |
| Interest Expense | 604.2 Thousand | - | 985.69 Thousand | - | - | 397.44 Thousand |
| Income Tax Expense | -437.27 Thousand | -25.72 Thousand | -3.53 Million | -3.53 Million | - | 3.00 |
| Earnings before Tax | -763.41 Thousand | -763.41 Thousand | -16 Million | -8.32 Million | -2.39 Million | -7.68 Million |
| Net Income | -763.41 Thousand | -763.41 Thousand | -12.47 Million | -4.79 Million | -2.39 Million | -7.68 Million |
| Earnings Per Share Basic | -0.02 | -0.02 | - | -0.15 | -0.07 | -0.27 |
| Earnings Per Share Diluted | -0.02 | -0.02 | - | -0.15 | -0.07 | -0.27 |
| Weighted Average Shares Outstanding | 32.62 Million | 32.62 Million | 30.48 Million | 32.64 Million | 32.72 Million | 28.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 32.62 Million | 32.62 Million | 30.48 Million | 32.64 Million | 32.72 Million | 28.24 Million |
| Gross Margin | 0.80 | 0.80 | -3.85 | -1.04 | 0.29 | -0.60 |
| EBIT Margin | -0.33 | -0.33 | - | -9.99 | -0.92 | -9.63 |
| Profit Margin | -0.93 | -0.93 | -11.52 | -6.42 | -1.12 | -11.13 |
| EBITDA | -269.15 Thousand | -269.15 Thousand | - | -7.45 Million | -1.96 Million | -6.64 Million |
| Earnings Before Tax Margin | -0.53 | -0.53 | -14.44 | -10.79 | -1.06 | -10.47 |
EQ
FCTI
INPAP
002805
603381
1030